IL-1β, IL-10 and TNF-α polymorphisms may affect systemic lupus erythematosus risk and phenotype

Clin Exp Rheumatol. 2022 Sep;40(9):1708-1717. doi: 10.55563/clinexprheumatol/qdgq0v. Epub 2022 Jan 5.

Abstract

Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease, and IL-1β, IL-10, and TNF-α genes are important in the pathogenesis of this disease. We studied the impact of IL-1β-511, IL-1β +3953, IL-10 -592, IL-10 -1082, TNF-α -308, TNF-α -238, and TNF-α +489 polymorphisms on SLE risk and phenotype in SLE patients and healthy controls.

Methods: We genotyped SLE patients and healthy controls by real-time PCR on QuantStudio 5 (Applied Biosystems) and measured levels of cytokines by enzyme-linked immunosorbent assay (ELISA).

Results: We indicated that TNF-α -308, IL-10 -592, IL-10 -1082, IL-1β-511 and IL-1β +3953 polymorphisms affect SLE risk. Furthermore, we exposed that some of the TNF-α +489, TNF-α -238, IL-10 -1082 and IL-1β +3953 genotypes are connected with the SLE phenotype. Moreover, we discovered the linking between specific genotypes and the serum concentrations of TNF-α, IL-1β, and IL-10.

Conclusions: In conclusion, our study revealed that IL-1β-511, IL-1β +3953, IL-10 -592, IL-10 -1082, and TNF-α -308 polymorphisms may affect SLE risk and phenotype.

MeSH terms

  • Cytokines
  • Genotype
  • Humans
  • Interleukin-10* / blood
  • Interleukin-10* / genetics
  • Interleukin-1beta* / blood
  • Interleukin-1beta* / genetics
  • Lupus Erythematosus, Systemic* / blood
  • Lupus Erythematosus, Systemic* / diagnosis
  • Lupus Erythematosus, Systemic* / genetics
  • Phenotype
  • Polymorphism, Genetic
  • Tumor Necrosis Factor-alpha* / blood
  • Tumor Necrosis Factor-alpha* / genetics

Substances

  • Cytokines
  • IL10 protein, human
  • IL1B protein, human
  • Interleukin-1beta
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • Interleukin-10